Facebook Linkedin Soundcloud Twitter Vimeo Xing
Home Tags Seattle Genentech

Tag: Seattle Genentech

Phase I Trial of SGN-CD352A in Relapsed or Refractory Multiple Myeloma...

Sonia Portillo
This week the first patient enrolled in a multi-center phase I clinical trial of SGN-CD352A for the treatment of patients with relapsed or refractory...

From the Editors: Welcome to a New Publication – ADC Review/Journal...

Peter Hofland
Welcome to ADC Review, Journal of Antibody-Drug Conjugates, a new online, peer-reviewed, open-access hybrid publication for those involved in the ongoing--and exciting--development of antibody-drug...
ADC Review, Journal of Antibody-drug Conjugates
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.

Latest

Peer Review

© 2013-2020 Sunvalley Communication, LLC. All Rights Reserved.

X